DarioHealth Corp. Common Stock (DRIO)
Stock · NASDAQ · Health Care
$5as of 10/16/2026
Price chart
DRIO Signal Track Record
How signals performed across all stocks →What DRIO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 25 | -2.0% | 48% | October 1, 2026 |
| Volume Spike | 20 | -5.7% | 35% | October 1, 2026 |
| Bollinger Band Breakout | 16 | -5.3% | 25% | July 22, 2026 |
| 200-Day Moving Average TouchActive now | 6 | -14.3% | 17% | December 11, 2025 |
| Any 20-session window (baseline) | -5.6% | 36% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About DRIO
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 160
- Website
- shop.mydario.com/
Fundamentals
- 1-day range
- $4.82$5.4
- Market cap
- $56.88M
- P/E (trailing)
- —
- P/E (forward)
- -4.30
- EPS (trailing)
- $-6.58
- Dividend yield
- —
- Beta
- 1.07
- Avg. volume
- 24.9K
- Dividend pay date
- November 18, 2019
How DarioHealth Corp. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 19, 2026 · via SEC EDGAR / Finnhub
Forecasts
5 analyst ratings
DarioHealth Corp. Common Stock Competitors
Chosen by industry and closest market cap.
- DRIODarioHealth Corp. Common Stock$4.82▼ 6.04%Market cap $56.88MP/E —$5.03$16.5
- NYXHNyxoah SA Ordinary Shares$1.11▼ 6.72%Market cap $57.20MP/E —$1.11$5.3
- QTEXQTREX Quantum Ltd. Ordinary Shares$1.5▼ 5.06%Market cap $59.05MP/E —$0.283$3.85
- MDAISpectral AI Inc. Class A Common Stock$1.51▼ 1.95%Market cap $52.83MP/E —$1.18$2.97
- DXRDaxor Corporation Common Stock$10.05▼ 1.47%Market cap $61.18MP/E 10.12$8.56$14.76
- XTNTXtant Medical Holdings Inc. Common Stock$0.29▼ 3.33%Market cap $62.09MP/E 23.84$0.2702$0.95
- SNWVSANUWAVE Health Inc. Common Stock$4.96▼ 4.06%Market cap $51.59MP/E 3.11$3.92$36.42
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DRIO DarioHealth Corp. Common Stock | $56.88M | — | $4.82 | ▼ 6.04% | $5.03$16.5 |
| NYXH Nyxoah SA Ordinary Shares | $57.20M | — | $1.11 | ▼ 6.72% | $1.11$5.3 |
| QTEX QTREX Quantum Ltd. Ordinary Shares | $59.05M | — | $1.5 | ▼ 5.06% | $0.283$3.85 |
| MDAI Spectral AI Inc. Class A Common Stock | $52.83M | — | $1.51 | ▼ 1.95% | $1.18$2.97 |
| DXR Daxor Corporation Common Stock | $61.18M | 10.12 | $10.05 | ▼ 1.47% | $8.56$14.76 |
| XTNT Xtant Medical Holdings Inc. Common Stock | $62.09M | 23.84 | $0.29 | ▼ 3.33% | $0.2702$0.95 |
| SNWV SANUWAVE Health Inc. Common Stock | $51.59M | 3.11 | $4.96 | ▼ 4.06% | $3.92$36.42 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Yoav Shaked · September 24, 2026 · Grant54.0K
- Chen Franco-Yehuda · September 24, 2026 · Grant95.0K
- Dennis Matheis · September 24, 2026 · Grant44.0K
- Hila Karah · September 24, 2026 · Grant28.0K
- Erez Raphael · September 24, 2026 · Grant297.0K
- Adam K. Stern · September 24, 2026 · Grant28.0K
- Dennis M. McGrath · September 24, 2026 · Grant61.0K
- John R. Palumbo · September 24, 2026 · Grant62.0K
- Dennis Matheis · July 23, 2026 · Buy14.4K @ $6.93
Institutional Ownership
March 31, 2026
- Total shares held
- 809.2K
- Total value held
- $6.49M
- Institutional holders
- 18
- Unknown610.7K
- Unknown65.9K
- Unknown61.9K
- Unknown20.5K
- Unknown18.8K
- Unknown15.9K
- Unknown13.2K
- Unknown1.0K
- Unknown448
- Unknown448
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
DarioHealth's Aon Analysis Confirms 2.5%-7.2% Cost Reduction
DarioHealth released an independent Aon analysis that backs its estimate of a 2.5%–7.2% reduction in in‑year healthcare costs. The study adds credibility to the company’s cost‑efficiency claims and may influence how analysts view its valuation. The stock is trading near its $7.38 support level, within the 52‑week range of $5.84–$17.74. The analysis could affect investor sentiment as the company continues to pursue its growth strategy.
DarioHealth's Aon Analysis Confirms 2.5%-7.2% Cost Reduction. DarioHealth released an independent Aon analysis that backs its estimate of a 2.5%–7.2% reduction in in‑year healthcare costs. The study adds credibility to the company’s cost‑efficiency claims and may influence how analysts view its valuation. The stock is trading near its $7.38 support level, within the 52‑week range of $5.84–$17.74. The analysis could affect investor sentiment as the company continues to pursue its growth strategy.